Literature DB >> 16285251

The use of pancreas biopsy scoring provides reliable porcine islet yields while encapsulation permits the determination of microbiological safety.

Lawrence S Gazda1, Hollie Adkins, Johannah A Bailie, Wendy Byrd, Lisa Circle, Bryan Conn, Carolyn H Diehl, Richard D Hall, Albert L Rubin, Barry H Smith.   

Abstract

For clinical xenogenic islet transplantation to be successful, several requirements must be met. Among them is a sizeable and reliable source of fully functional and microbiologically safe islets. The inherent variability among porcine pancreases, with respect to islet yield, prompted us to develop a Biopsy Score technique to determine the suitability of each pancreas for islet isolation processing. The Biopsy Score consists of an assessment of five variables: warm ischemia time, pancreas color, fat content, islet size, and islet demarcation, each of which is assigned a value of -1 or +1, depending on whether or not the established criteria is met. For determination of islet size and demarcation, fresh biopsies of porcine pancreases are stained with dithizone (DTZ) solution and examined under a dissecting microscope. Based on the scoring of such biopsies in pancreases from 26-56-month-old sows, we report here that the presence of large (>100 microm diameter), well-demarcated islets in the pancreas biopsy is a reliable predictor of isolation success. Encapsulation of the isolated porcine islets within the inner layer of a 1.5% agarose and an outer layer of 5.0% agarose macrobead, containing 500 equivalent islet number (EIN), provides for extended in vitro functional viability (>6 months of insulin production in response to glucose), as well as for comprehensive microbiological testing and at least partial isolation of the xenogeneic islets from the host immune system. All microbiological testing to date has been negative, except for the presence of porcine endogenous retrovirus (PERV). Taken together, we believe that the Biopsy Score enhancement of our islet isolation technique and our agarose-agarose macroencapsulation methodology bring us significantly closer to realizing clinical porcine islet xenotransplantation for the treatment of insulin-dependent diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16285251     DOI: 10.3727/000000005783982846

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  7 in total

Review 1.  Optimal pig donor selection in islet xenotransplantation: current status and future perspectives.

Authors:  Hai-tao Zhu; Liang Yu; Yi Lyu; Bo Wang
Journal:  J Zhejiang Univ Sci B       Date:  2014-08       Impact factor: 3.066

2.  Rapid quantitative assessment of the pig pancreas biopsy predicts islet yield.

Authors:  T Anazawa; A N Balamurugan; S Matsumoto; S A Lafreniere; T D O'Brien; D E R Sutherland; B J Hering
Journal:  Transplant Proc       Date:  2010 Jul-Aug       Impact factor: 1.066

Review 3.  Current status of islet cell transplantation.

Authors:  Hirohito Ichii; Camillo Ricordi
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-12-26

Review 4.  Pig-islet xenotransplantation: recent progress and current perspectives.

Authors:  Hai-Tao Zhu; Wan-Li Wang; Liang Yu; Bo Wang
Journal:  Front Surg       Date:  2014-03-24

5.  Optimizing Porcine Islet Isolation to Markedly Reduce Enzyme Consumption Without Sacrificing Islet Yield or Function.

Authors:  Robert W Holdcraft; Michael L Green; Andrew G Breite; Lisa Circle; Eric D Meyer; Hollie Adkins; Steven G Harbeck; Barry H Smith; Lawrence S Gazda
Journal:  Transplant Direct       Date:  2016-06-06

6.  A comprehensive microbiological safety approach for agarose encapsulated porcine islets intended for clinical trials.

Authors:  Lawrence S Gazda; James Collins; Archie Lovatt; Robert W Holdcraft; Merribeth J Morin; Daniel Galbraith; Melanie Graham; Melissa A Laramore; Christine Maclean; John Black; Euan W Milne; Douglas G Marthaler; Horatiu V Vinerean; Michelle M Michalak; Deborah Hoffer; Steven Richter; Richard D Hall; Barry H Smith
Journal:  Xenotransplantation       Date:  2016-11-11       Impact factor: 3.907

7.  First-in-Human Phase 1 Trial of Agarose Beads Containing Murine RENCA Cells in Advanced Solid Tumors.

Authors:  Barry H Smith; Tapan Parikh; Zoe P Andrada; Thomas J Fahey; Nathaniel Berman; Madeline Wiles; Angelica Nazarian; Joanne Thomas; Anna Arreglado; Eugene Akahoho; David J Wolf; Daniel M Levine; Thomas S Parker; Lawrence S Gazda; Allyson J Ocean
Journal:  Cancer Growth Metastasis       Date:  2016-08-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.